No CD4 + count criterion was imposed, prior treatment allowances were broad, enrollment of patients on treatment interruptions of at least 4 weeks was allowed, and investigators
were permitted to enroll patients actively using illicit drugs or alcohol if they believed the patient could comply with the study protocol.